There are several alternatives to semaglutide, all of which offer the potential for successful management of blood sugar levels
Not in the way the headlines suggest
Tirzepatide, marketed as Mounjaro for diabetes and Zepbound for weight management, works by activating GLP-1 and GIP receptors to regulate appetite and blood sugar
Read our learning article for practical advice on safe and effective switching between weight loss medication: Switching between weight-loss medications Stopping GLP-1s There is some evidence to suggest that rapid weight loss is much more effective than gradual weight loss in achieving and sustaining a clinically meaningful drop in weight
OnlineSemaglutide.org (9.4): Transparent pharmacy and prescriber network
The test program, known as BALANCE, was scheduled to run in Part D through 2031 and would have covered all formulations of Mounjaro, Ozempic, Rybelsus and Wegovy, along with the KwikPen formulation of Foundayo and Zepbound